New approaches for developing disease modifying therapies in Alzheimer's disease

PSY Therapeutics - New Approach to Tackling Alzheimer's DiseaseПодробнее

PSY Therapeutics - New Approach to Tackling Alzheimer's Disease

Janssen: 'Every 3 Seconds'Подробнее

Janssen: 'Every 3 Seconds'

Current and Future Strategies to Treat and Prevent Alzheimer’s DiseaseПодробнее

Current and Future Strategies to Treat and Prevent Alzheimer’s Disease

Lecanemab (Leqembi) Alzheimer's diseaseПодробнее

Lecanemab (Leqembi) Alzheimer's disease

Bringing new approaches to developing treatments for MNDПодробнее

Bringing new approaches to developing treatments for MND

Webinar: "New Treatments in Testing to Slow or Stop Parkinson's" November 2019Подробнее

Webinar: 'New Treatments in Testing to Slow or Stop Parkinson's' November 2019

Actinogen Medical: Taking a new approach to the treatment of Alzheimer’s diseaseПодробнее

Actinogen Medical: Taking a new approach to the treatment of Alzheimer’s disease

Novel Approaches to the Treatment of Alzheimers DiseaseПодробнее

Novel Approaches to the Treatment of Alzheimers Disease

Clinical development of novel pharmacological treatments for Alzheimer's diseaseПодробнее

Clinical development of novel pharmacological treatments for Alzheimer's disease

Alzheimer’s Disease: New Approaches to Treatment and PreventionПодробнее

Alzheimer’s Disease: New Approaches to Treatment and Prevention

Modern Medicine: New approaches to Alzheimer'sПодробнее

Modern Medicine: New approaches to Alzheimer's

New approaches for developing disease modifying therapies in Alzheimer's diseaseПодробнее

New approaches for developing disease modifying therapies in Alzheimer's disease

Approaches to Aging and Alzheimer’s: What are We Learning from Clinical Trials? - Rachelle DoodyПодробнее

Approaches to Aging and Alzheimer’s: What are We Learning from Clinical Trials? - Rachelle Doody